ENXTPA:AKEChemicals
Arkema (ENXTPA:AKE) Grapples With Lower Q3 Profits Is Its Growth Story at a Turning Point?
Arkema S.A. reported third quarter 2025 earnings showing sales of €2,187 million and net income of €35 million, both down from the previous year.
The company also saw significant declines in earnings per share, highlighting ongoing operational and demand-related challenges.
With profits and earnings per share dropping sharply, we'll consider how this impacts expectations for Arkema's recovery and future growth profile.
Outshine the giants: these 27 early-stage AI stocks could fund your...